120 related articles for article (PubMed ID: 11025704)
1. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.
Barry MJ; Williford WO; Fowler FJ; Jones KM; Lepor H
J Urol; 2000 Nov; 164(5):1559-64. PubMed ID: 11025704
[TBL] [Abstract][Full Text] [Related]
2. Do reported micturition symptoms on the American Urological Association Questionnaire correlate with 24-hour home uroflowmetry recordings?
Matzkin H; Greenstein A; Prager-Geller T; Sofer M; Braf Z
J Urol; 1996 Jan; 155(1):197-9. PubMed ID: 7490832
[TBL] [Abstract][Full Text] [Related]
3. Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four years.
Trock BJ; Brotzman M; Utz WJ; Ugarte RR; Kaplan SA; Larson TR; Blute ML; Roehrborn CG; Partin AW
Urology; 2004 Apr; 63(4):716-21. PubMed ID: 15072887
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of written screening tools in an inner city hospital: literacy based limitations on patient access to appropriate care.
Johnson TV; Goodman M; Master VA
J Urol; 2007 Aug; 178(2):623-9; discussion 629. PubMed ID: 17570427
[TBL] [Abstract][Full Text] [Related]
6. American Urological Association symptom index in the assessment of urethroplasty outcomes.
Morey AF; McAninch JW; Duckett CP; Rogers RS
J Urol; 1998 Apr; 159(4):1192-4. PubMed ID: 9507830
[TBL] [Abstract][Full Text] [Related]
7. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study.
Welch G; Kawachi I; Barry MJ; Giovannucci E; Colditz GA; Willett WC
Urology; 1998 Mar; 51(3):422-7. PubMed ID: 9510347
[TBL] [Abstract][Full Text] [Related]
8. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
Matoka DJ; Averch TD
Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
[TBL] [Abstract][Full Text] [Related]
9. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the comprehension of the American Urological Association Symptom Index.
MacDiarmid SA; Goodson TC; Holmes TM; Martin PR; Doyle RB
J Urol; 1998 Mar; 159(3):873-4. PubMed ID: 9474172
[TBL] [Abstract][Full Text] [Related]
11. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures.
Nitti VW; Lefkowitz G; Ficazzola M; Dixon CM
J Urol; 2002 Jul; 168(1):135-8. PubMed ID: 12050507
[TBL] [Abstract][Full Text] [Related]
12. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
Helfand B; Mouli S; Dedhia R; McVary KT
J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
14. Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.
Twiss C; Triaca V; Anger J; Patel M; Smith A; Kim JH; Raz S; RodrÃguez LV
J Urol; 2009 Nov; 182(5):2384-91. PubMed ID: 19758631
[TBL] [Abstract][Full Text] [Related]
15. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia.
Chancellor MB; Rivas DA
J Urol; 1993 Nov; 150(5 Pt 2):1706-8; discussion 1708-9. PubMed ID: 7692106
[TBL] [Abstract][Full Text] [Related]
16. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
Haltbakk J; Hanestad BR; Hunskaar S
BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
[TBL] [Abstract][Full Text] [Related]
17. Overlap of voiding symptoms, storage symptoms and pain in men and women.
Clemens JQ; Markossian TW; Meenan RT; O'Keeffe Rosetti MC; Calhoun EA
J Urol; 2007 Oct; 178(4 Pt 1):1354-8; discussion 1358. PubMed ID: 17706719
[TBL] [Abstract][Full Text] [Related]
18. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
19. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
